Trials / Recruiting
RecruitingNCT05973656
Role of Acetaldehyde in the Development of Oral Cancer
Dissecting the Role of Acetaldehyde in Oral Carcinogenesis
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 170 (estimated)
- Sponsor
- Masonic Cancer Center, University of Minnesota · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a minimal risk intervention study where healthy volunteers and individuals with Fanconi anemia will consume a single dose of alcohol and provide primarily non-invasive biological samples at various time points. Biospecimens to be collected include saliva, oral cells collected via mouthwash and cheek brush, and urine. The collection of two blood samples (5 mL each) will be optional and banked for future use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alcohol | Alcohol dose given orally that will result in a 0.03% blood alcohol concentration (BAC). |
| PROCEDURE | Biospecimen Collection | Undergo saliva, mouthwash, and cheek brush collection |
| PROCEDURE | Breath Test | Undergo breathalyzer testing |
Timeline
- Start date
- 2022-07-08
- Primary completion
- 2026-11-30
- Completion
- 2027-09-30
- First posted
- 2023-08-03
- Last updated
- 2025-08-22
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05973656. Inclusion in this directory is not an endorsement.